NASD
| Health Care |
Biotechnology
Edgewise Therapeutics Inc. (EWTX)
LAST (3 Apr)
After-Hours (19:30:25 ET)
MARKET CAP
VOLUME
| Open | 14.90 |
| Previous Close | 15.52 |
| Day Range | 12.59 - 14.90 |
| 52-Week Range | 12.18 - 38.12 |
| All-Time High | 40.49 |
| Avg. Volume (50-day) | 1,669,525.9 |
| EPS (TTM) | -1.45 |
| Next Earnings Date | 2025-05-08 (BMO) |
| Last Earnings Date | 2025-03-03 |
| Forward Annual Dividend (Yield) | - |
| Trailing Annual Dividend (Yield) | - |
| Options | Yes |
| P/E Ratio | -10.74 |
| PEG Ratio | - |
| Price to Book | 3.21 |
| Price to Cash Flow | - |
| Price to Free Cash Flow | - |
| Total Sales (TTM) | - |
| Revenue per Share (TTM) | - |
| Shares Outstanding | 95.205 M |
| Share Float (%) | 67.23 M |
| % Held by Institutions | 78.77 |
| Dividends Per Share (TTM) | - |
| Ex-Dividend Date | - |
| +/- EMA(20) | 22.31 (-39.13%) |
| +/- SMA(50) | 25.57 (-46.89%) |
| +/- SMA(200) | 25.44 (-46.62%) |
| 5-Day Perf. | -42.06% |
| 1-Month Perf. | -46.81% |
| 3-Month Perf. | -51.01% |
| 6-Month Perf. | -49% |
| YTD Perf. | -49.14% |
| 1-Year Perf. | -26.59% |
| RSI(14) | 17.58 |
| ATR(14) | 2.47 |
| ADX(14) | 24.77 |
| Beta (5Y) | 1.50 |
FOR STOCKCHARTS MEMBERS ONLY
Unlock earnings and revenue history when you join StockCharts
As a StockCharts Member, you can review earnings results and analyze revenue and earnings growth over time. Bring a balance of technicals and fundamentals to your approach when you join today!
EWTX
Edgewise Therapeutics Inc.
Sector: Health Care
Industry: Biotechnology
Employees: 110
Description
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders for which there is significant unmet medical need. Its platform utilizes custom-built throughput and translatable systems that measure integrated muscle function in whole organ extracts to identify small molecule precision medicines regulating key proteins in muscle tissue, initially focused on addressing rare neuromuscular and cardiac diseases. The company was founded by Badreddin Edris, Alan Russel and Peter A. Thompson in 2017 and is headquartered in Boulder, CO.
EWTX has triggered the following predefined scans:
| No Recent Scan Appearances |
FOR STOCKCHARTS MEMBERS ONLY
Unlock custom technical alerts when you join StockCharts
As a StockCharts Member, you can create your own unique alerts with the technical criteria that matters most to you. Stay ahead of important moves and never miss a thing in the markets.
FOR STOCKCHARTS MEMBERS ONLY
Unlock ChartLists to save and organize your charts when you join StockCharts
As a StockCharts Member, you can save the charts you're watching to your own account with ChartLists. Accessible from any device, you can organize, review and analyze your charts on-the-go, anytime, anywhere.
